Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elisabetta Buscarini is active.

Publication


Featured researches published by Elisabetta Buscarini.


European Radiology | 2001

Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.

Luigi Buscarini; Elisabetta Buscarini; Michele Di Stasi; Daniele Vallisa; Pietro Quaretti; Andrea Rocca

Abstract The aim of this study was to evaluate the effectiveness and the safety of percutaneous radiofrequency (RF) thermal ablation of hepatocellular carcinoma (HCC) in 88 patients with a long follow-up, and to compare conventional electrodes and expandable electrodes. Eighty-eight patients with 101 hepatocellular carcinoma nodules (≤ 3.5 cm in diameter) underwent RF thermal ablation by means of either conventional electrodes or an expandable electrode. Therapeutic efficacy was evaluated with dynamic contrast CT, serum α-feto protein level, US examination at the end of the treatment, and during follow-up. Complete necrosis was obtained in all tumor nodules in a mean number of 3.3 sessions (tumor treated by conventional electrodes) or 1.5 sessions (tumor treated by expandable electrode). The mean follow-up was 34 months; overall survival rate was 33 % at 5 years. Disease-free survival at 5 years was 3 %; local recurrence rate was 29 % in patients treated with conventional electrodes; 14 % in patients treated with the expandable electrode. Two major complications and 14 minor complications were observed. Radiofrequency thermal ablation in small HCC is very effective with a low percentage of major complications. The use of an expandable electrode substantially reduced the number of treatment sessions but did not modify the overall survival rate and the disease-free survival rate.


Journal of Hepatology | 1997

Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family

Elisabetta Buscarini; Luigi Buscarini; Cesare Danesino; Mauro Piantanida; Giuseppe Civardi; Pietro Quaretti; Sandro Rossi; Michele Di Stasi; Matteo Silva

BACKGROUND/AIMS The prevalence of hepatic vascular malformations in hereditary hemorrhagic telangiectasia has been estimated in the literature on clinical criteria, thus giving unreliable data. In our study the presence of hepatic vascular malformations in hereditary hemorrhagic telangiectasia was evaluated in a large Italian family by using Doppler sonography findings were compared to computed tomography and angiography results. Clinical features were related to the severity of hepatic vascular malformations. METHODS Seventy-three relatives were checked for the presence of signs of hereditary hemorrhagic telangiectasia. Abdominal Doppler ultrasonography was performed in all of them. Every subject with a positive Doppler ultrasonography for hepatic vascular malformations underwent abdominal computed tomography and celiac angiography. RESULTS Forty family members proved to be affected by hereditary hemorrhagic telangiectasia. Of these, hepatic vascular malformations were evidenced by Doppler ultrasonography in 13 females. Doppler ultrasongraphy demonstrated minimal hepatic vascular abnormalities in three subjects, moderate in three, and severe in seven. Doppler study was diagnostic for arteriovenous shunt with hepatic veins in seven cases and with portal vein in two. Computed tomography failed to demonstrate hepatic vascular malformations in two cases, while angiography confirmed the Doppler sonographic findings in all cases. Cholestasis was present in subjects with moderate and severe hepatic vascular malformations. CONCLUSIONS Doppler sonography is the ideal imaging technique to screen hereditary hemorrhagic telangiectasia affected families for hepatic vascular malformations. These malformations do not appear to be age-dependent, but sex-dependent. Cholestasis is the main clinical sign, and it seems to correlate with the severity of hepatic vascular derangement.


European Radiology | 2004

Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report

Elisabetta Buscarini; Luigi Buscarini

The aim of this study was to describe type and rate of complications in a series of patients with liver tumors treated by the radiofrequency (RF) expandable system. A total of 166 patients, 114 with hepatocellular carcinoma (HCC; 92 small HCC, 22 large) and 52 with liver metastasis, were treated by the percutaneous RF expandable system. In large HCCs, RF ablation was performed after tumor ischemia (TAE or balloon stop flow of the hepatic artery). Major complications were those that delayed hospital discharge, with or without additional medical procedures or treatments. Minor complications did not require an additional hospital stay. No deaths occurred. Among 151 patients followed, there were 7 (4.6%) early major complications—severe pain with session interruption in 3 cases, capsular necrosis in 1 case, 1 abdominal wall necrosis, 1 dorsal burning, 1 peritoneal hemorrhage—and 3 (1.9%) delayed major complications: sterile fluid collection at the site of the treated tumor in 2 cases and cutaneous seeding in 1 case. There were 49 (32.5%) minor complications. The complication rate is similar to that observed after percutaneous alcohol injection (PEI). With the cooled system, the complication rate is seemingly lower but that may well be due to a different definition of major complications. The seeding rate after expandable system ablation is lower than after PEI. It is the same as or lower than that in other series of patients treated by the cooled system.


Gastrointestinal Endoscopy | 1995

Laparoscopic ablation of liver adenoma by radiofrequency electrocauthery

Luigi Buscarini; Sandro Rossi; F. Fornari; Michele Di Stasi; Elisabetta Buscarini

Two percutaneous and minimally invasive means of ablating small hepatocellular carcinomas (HCC) are (1) injection of ethanol guided by ultrasonography (US),1 and (2) interstitial hyperthermia induced by an electrode needle activated by radiofrequency (RF) or by insertion of a laser fiber, also under US guidance. 2, 3 The extent of necrosis induced by interstitial hyperthermia is exactly predictable. The size of the thermally induced lesion depends on the needle size, the temperature of the needle tip, and the e xposure time (however, exposure in excess of 120 seconds does not cause a further increase in the volume of necrosis). Keeping the tip temperature below 100 ° C at hottest focus within t he lesion will avoid boiling or sticking and the associated risks. 4, 5 The use of interstitial RF hyperthermia is similar to that employed in neurosurgery. 5 An RF electrode needle or laser fiber also may be inserted in the course of laparoscopy. A recent report described laser-assisted excision of a liver cyst using a laparoscopic approach. 6 We report here a case of adenoma, superficially located in the liver, treated by laparoscopically guided RF interstitial hyperthermia.


Journal of Clinical Ultrasound | 1996

Natural history of focal nodular hyperplasia of the liver : an ultrasound study

Michele Di Stasi; Eugenio Caturelli; Ilario de Sio; Andrea Salmi; Elisabetta Buscarini; Luigi Buscarini

Sixteen cases of focal nodular hyperplasia (FNH) of the liver were followed by ultrasound (US) for a mean of 33 months (range 6–81). In 69% of the cases, the diagnosis was incidental. On US the lesions were single in 75% of the cases, localized in the right lobe in 75%, and subcapsular in 50%. No specific US‐pattern could be identified. A central scar was found in 19% of the patients. At the end of the follow‐up, the size was reduced in 7/16 cases, and in 1/16 the lesion disappeared. The spontaneous reduction of nodules in FNH must be considered in the management of this pseudotumor.


Nutrients | 2016

Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: Results from a multicenter randomized double-blind placebo-controlled gluten challenge

Luca Elli; Carolina Tomba; Federica Branchi; Leda Roncoroni; Vincenza Lombardo; Maria Teresa Bardella; Francesca Ferretti; Dario Conte; F. Valiante; Lucia Fini; Edoardo Forti; Renato Cannizzaro; Stefania Maiero; Claudio Londoni; Adriano Lauri; Giovanni Fornaciari; Nicoletta Lenoci; Rocco Spagnuolo; G. Basilisco; Francesco Somalvico; Gioacchino Leandro; Sergio Segato; Donatella Barisani; Gaetano Morreale; Elisabetta Buscarini

Non-celiac gluten sensitivity (NCGS) is characterized by the onset of symptoms after eating gluten-containing food. We aimed to single out NCGS subjects among subjects with functional gastrointestinal symptoms. Patients were enrolled in a multicenter double-blind placebo-controlled trial with crossover. Symptoms and quality of life were evaluated by means of 10-cm VAS and SF36. Iron parameters, transaminases and C reactive protein (CRP) were evaluated. After a three-week-long gluten-free diet (GFD), responsive patients were randomly assigned to gluten intake (5.6 g/day) or placebo for seven days, followed by crossover. The primary endpoint was the worsening of symptoms (VAS increase ≥3 cm) during gluten ingestion compared to placebo. One hundred and forty patients were enrolled and 134 (17 males, mean age 39.1 ± 11.7 years, BMI 22.4 ± 3.8) completed the first period. A total of 101 subjects (10 males, mean age 39.3 ± 11.0 years, BMI 22.3 ± 4.0) reported a symptomatic improvement (VAS score 2.3 ± 1.2 vs. 6.5 ± 2.2 before and after GFD, p = 0.001). 98 patients underwent the gluten challenge and 28 (all females, mean age 38.9 ± 12.7 years, BMI 22.0 ± 2.9) reported a symptomatic relapse and deterioration of quality of life. No parameters were found to be statistically associated with positivity to the challenge. However, 14 patients responded to the placebo ingestion. Taking into account this finding, about 14% of patients responding to gluten withdrawal showed a symptomatic relapse during the gluten challenge. This group is suspected to have NCGS.


Gastrointestinal Endoscopy | 1999

Endosonographic diagnosis of submucosal upper gastrointestinal tract lesions and large fold gastropathies by catheter ultrasound probe

Elisabetta Buscarini; Michele Di Stasi; Sandro Rossi; Matteo Silva; Francesco Giangregorio; Zangrandi Adriano; Luigi Buscarini

BACKGROUND The unique ability of EUS to depict wall layers makes it possible to accurately evaluate submucosal lesions of the digestive tract and large-fold gastropathies. Although EUS requires a second endoscopic examination, miniature US probes introduced through the accessory channel of a conventional endoscope permit US examination during routine endoscopy. METHODS By means of catheter probe sonography and conventional EUS, we evaluated 33 patients with a radiographic or endoscopic finding of a submucosal lesion of the upper GI tract or with large-fold gastropathies and histologically negative biopsies obtained at a previous endoscopy. A miniature multifrequency probe was used for catheter probe sonography. RESULTS For 25 submucosal lesions catheter probe sonography results were superimposable on those obtained with EUS. In evaluating submucosal lesions, catheter probe sonography yielded the same results as conventional EUS in terms of depiction, measurement, and identification of the originating layer of the tumor. In the study of 8 large-fold gastropathies, catheter probe sonography missed the presence of ascites and enlarged lymph nodes in a case of gastric linitis, but produced the same results as conventional EUS in the other cases. CONCLUSIONS For the evaluation of benign submucosal lesions and large-fold gastropathies, catheter probe sonography appears to be sufficient and could thus replace conventional EUS for these indications.


Digestive and Liver Disease | 2014

Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms.

Elisabetta Buscarini; Raffaele Pezzilli; Renato Cannizzaro; Claudio De Angelis; Massimo Gion; Giovanni Morana; Giuseppe Zamboni; Paolo Giorgio Arcidiacono; Gianpaolo Balzano; Luca Barresi; Daniela Basso; Paolo Bocus; Lucia Calculli; Gabriele Capurso; Vincenzo Canzonieri; Riccardo Casadei; Stefano Crippa; Mirko D’Onofrio; Luca Frulloni; Pietro Fusaroli; Guido Manfredi; Donatella Pacchioni; Claudio Pasquali; Rodolfo Rocca; Maurizio Ventrucci; Silvia Venturini; Vincenzo Villanacci; Alessandro Zerbi; M. Falconi; Luca Albarello

This report contains clinically oriented guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms in patients fit for treatment. The statements were elaborated by working groups of experts by searching and analysing the literature, and then underwent a consensus process using a modified Delphi procedure. The statements report recommendations regarding the most appropriate use and timing of various imaging techniques and of endoscopic ultrasound, the role of circulating and intracystic markers and the pathologic evaluation for the diagnosis and follow-up of cystic pancreatic neoplasms.


European Journal of Gastroenterology & Hepatology | 2011

Endoscopic ultrasonography versus endoscopic retrograde cholangiopancreatography in acute biliary pancreatitis: a systematic review.

Stefania De Lisi; Gioacchino Leandro; Elisabetta Buscarini

Background Acute biliary pancreatitis (ABP) is a clinical condition that can rapidly evolve into a life-threatening one. Endoscopic retrograde cholangiopancreatography (ERCP) has been considered the standard treatment of ABP for many years, though it entails the risk of morbidity and mortality. Endoscopic ultrasonography (EUS) can reliably diagnose choledocholithiasis avoiding unnecessary ERCP in patients with no stones in the biliary tract. Aim We undertook a systematic review of the randomized controlled trials and clinical trials comparing EUS and ERCP to evaluate procedure performance, complication rates, clinical course of pancreatitis, and hospital stay according to the treatment given. Methods A computerized bibliographic search was performed from 1994 to April 2010. Two reviewers assessed the methodological quality of eligible trials and independently extracted data from the included trials. Results Seven studies enrolled 545 patients with acute pancreatitis of suspected biliary origin. Only one was a randomized controlled trial. EUS had a lower failure rate than ERCP in all the studies included, avoiding ERCP in 71.2% of cases. No complications were related to EUS, whereas sphincterotomy was associated with bleeding in up to 22% of patients. The procedures did not influence the clinical course of pancreatitis. Conclusion A strategy based on EUS before ERCP in patients with ABP may be an effective alternative to diagnostic ERCP.


Alimentary Pharmacology & Therapeutics | 2002

The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma

Giancarlo Caletti; Pier Luigi Zinzani; Pietro Fusaroli; Elisabetta Buscarini; Fabrizio Parente; T. Federici; Sergio Peyre; C. De Angelis; G. Bonanno; Thomas Togliani; Stefano Pileri; S. Tura

Background : Anti‐Helicobacter pylori therapy has been reported to cause regression of low‐grade gastric mucosa‐associated lymphoid tissue lymphoma in a high percentage of patients. However, in some patients, these lesions persist despite antibiotic treatment.

Collaboration


Dive into the Elisabetta Buscarini's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dario Conte

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar

Luca Elli

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar

Paolo Giorgio Arcidiacono

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge